LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company engaged in the development and commercialization of therapeutics based on molecular chaperone regulation, today announced that Steven A. Kriegsman, President and Chief Executive Officer, will make a presentation at the UBS Global Life Sciences Conference on Wednesday, September 24, 2008 at 10:00 a.m. EDT. The conference will be held at The Grand Hyatt Hotel in New York, NY.
